Endophthalmitis after intravitreal injections: Incidence, presentation, management, and visual outcome

American Journal of Ophthalmology

Volumn 160, Issue 1, 2015, Pages 17-25.e1

  Dossarps, Denis ^a   Bron, Alain M ^a   Koehrer, Philippe ^a   Aho Glélé, Ludwig S ^a   Creuzot Garcher, Catherine ^a   Berthon, Laurent ^b   Maftouhi, Quaranta El ^b   Bakhti, Amina ^b   Conrath, John ^b   Le Mer, Yannick ^b   Ramahefasolo, Christiane Besse ^b   Coscas, Florence ^b   Français, Catherine ^b   Grenet, Typhaine ^b   Cohen, Salomon Yves ^b   Uzzan, Joël ^b   Razavi, Sam ^b   Saleh, Maher ^b   Delbosc, Bernard ^b   Chaine, Gilles ^b   Fajnkuchen, Franck ^b   Giocanti, Audrey ^b   Delyfer, Marie Noëlle ^b   Korobelnik, Jean François ^b   Querques, Giuseppe ^b   Chevreaud, Olivier ^b   Souied, Eric ^b   Musson, Cécile ^b   Chiquet, Christophe ^b   Fortoul, Vincent ^b   Kodjikian, Laurent ^b   Straub, Morgane ^b   Burillon, Carole ^b   Berrod, Jean Paul ^b   Baillif, Stéphanie ^b   Girmens, Jean François ^b   Pérol, Julien ^b   Leveziel, Nicolas ^b   Boissonnot, Michèle ^b   Muraine, Marc ^b   Gaucher, David ^b   Le Lez, Marie Laure ^b   Pisella, Pierre Jean ^b   more..

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CEFTAZIDIME; CIPROFLOXACIN; DEXAMETHASONE; DEXAMETHASONE SODIUM PHOSPHATE; IMIPENEM; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VANCOMYCIN; ANGIOGENESIS INHIBITOR; ANTIINFECTIVE AGENT; GLUCOCORTICOID;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIOLOGY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORTICOSTEROID THERAPY; DEGENERATIVE MYOPIA; DIABETIC RETINOPATHY; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; FRANCE; GRAM POSITIVE BACTERIUM; HUMAN; INCIDENCE; MACULAR EDEMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; TREATMENT INDICATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; ADVERSE EFFECTS; BACTERIUM; CLINICAL TRIAL; EYE INFECTIONS, BACTERIAL; INTRAVITREAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PHYSIOLOGY; RETINAL DISEASES; RISK FACTOR; VERY ELDERLY; VITREOUS BODY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTI-BACTERIAL AGENTS; BACTERIA; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; FRANCE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RETINAL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; VISUAL ACUITY; VITREOUS BODY;

EID: 84930960168     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2015.04.013     Document Type: Article

References (40)

1. G.A. Peyman, E.M. Lad, and D.M. Moshfeghi Intravitreal injection of therapeutic agents Retina 29 7 2009 875 912
2. M.I. van der Reis, E.C. La Heij, Y. De Jong-Hesse, P.J. Ringens, F. Hendrikse, and J.S. Schouten A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections Retina 31 8 2011 1449 1469
3. T. Brynskov, H. Kemp, and T.L. Sorensen No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting Retina 34 5 2014 951 957
4. S. Day, K. Acquah, P. Mruthyunjaya, D.S. Grossman, P.P. Lee, and F.A. Sloan Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration Am J Ophthalmol 152 2 2011 266 272
5. J.B. Fileta, I.U. Scott, and H.W. Flynn Jr. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents Ophthalmic Surg Lasers Imaging Retina 45 2 2014 143 149
6. C.A. McCannel Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies Retina 31 4 2011 654 661
7. P.J. Rosenfeld, D.M. Brown, and J.S. Heier Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431
8. L.P. Aiello, A.J. Brucker, and S. Chang Evolving guidelines for intravitreous injections Retina 24 5 Suppl 2004 S3 19
9. B. Bodaghi, J.F. Korobelnik, I. Cochereau, J. Hajjar, F. Goebel, and N. Dumarcet [Intravitreal injections: AFSSAPS guide to good practice] J Fr Ophtalmol 35 1 2012 69 71
10. J.T. Holladay Proper method for calculating average visual acuity J Refract Surg 13 4 1997 388 391
11. J. IntHout, J.P. Ioannidis, and G.F. Borm The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method BMC Med Res Methodol 14 2014 25
12. H. Casparis, T.J. Wolfensberger, and M. Becker Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study Retina 34 1 2014 12 17
13. E. Chen, M.Y. Lin, J. Cox, and D.M. Brown Endophthalmitis after intravitreal injection: the importance of viridans streptococci Retina 31 8 2011 1525 1533
14. D.R. Fintak, G.K. Shah, and K.J. Blinder Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab Retina 28 10 2008 1395 1399
15. K.S. Klein, M.K. Walsh, and T.S. Hassan Endophthalmitis after anti-VEGF injections Ophthalmology 116 6 2009 1225
16. D.A. Lyall, A. Tey, and B. Foot Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes Eye (Lond) 26 12 2012 1517 1526
17. A.A. Moshfeghi, P.J. Rosenfeld, and H.W. Flynn Jr. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six-year experience at a university referral center Retina 31 4 2011 662 668
18. M.M. Nentwich, Y. Yactayo-Miranda, F. Schwarzbach, A. Wolf, and A. Kampik Mino de Kaspar H. Endophthalmitis after intravitreal injection: decreasing incidence and clinical outcome-8-year results from a tertiary ophthalmic referral center Retina 34 5 2014 943 950
19. C.P. Shah, S.J. Garg, J.F. Vander, G.C. Brown, R.S. Kaiser, and J.A. Haller Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents Ophthalmology 118 10 2011 2028 2034
20. P. Storey, M. Dollin, and J. Pitcher The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection Ophthalmology 121 1 2014 283 289
21. D.M. Brown, M. Michels, P.K. Kaiser, J.S. Heier, J.P. Sy, and T. Ianchulev Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study Ophthalmology 116 1 2009 57 65
22. A.E. Green-Simms, N.S. Ekdawi, and S.J. Bakri Survey of intravitreal injection techniques among retinal specialists in the United States Am J Ophthalmol 151 2 2011 329 332
23. R.G. Abell, N.M. Kerr, P. Allen, and B.J. Vote Intravitreal injections: is there benefit for a theatre setting? Br J Ophthalmol 96 12 2012 1474 1478
24. J.J. de Caro, C.N. Ta, and H.K. Ho Bacterial contamination of ocular surface and needles in patients undergoing intravitreal injections Retina 28 6 2008 877 883
25. A.R. Bhavsar, J.M. Googe Jr., and C.R. Stockdale Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 12 2009 1581 1583
26. C.N. Ta Minimizing the risk of endophthalmitis following intravitreous injections Retina 24 5 2004 699 705
27. S.S. Bhatt, K.E. Stepien, and K. Joshi Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate Retina 31 10 2011 2032 2036
28. R.W. Chen, A. Rachitskaya, I.U. Scott, and H.W. Flynn Jr. Is the use of topical antibiotics for intravitreal injections the standard of care or are we better off without antibiotics? JAMA Ophthalmol 131 7 2013 840 842
29. C.S. Cheung, A.W. Wong, A. Lui, P.J. Kertes, R.G. Devenyi, and W.C. Lam Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections Ophthalmology 119 8 2012 1609 1614
30. V.T. Yin, D.J. Weisbrod, and K.T. Eng Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection JAMA Ophthalmol 131 4 2013 456 461
31. J.M. Moss, S.R. Sanislo, and C.N. Ta A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections Ophthalmology 116 8 2009 1498 1501
32. A.M. Schimel, I.U. Scott, and H.W. Flynn Jr. Endophthalmitis after intravitreal injections: should the use of face masks be the standard of care? Arch Ophthalmol 129 12 2011 1607 1609
33. D.A. Friedman, J.O. Mason 3rd, T. Emond, and G. McGwin Jr. Povidone-iodine contact time and lid speculum use during intravitreal injection Retina 33 5 2013 975 981
34. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham Jr., M. Feinsod, and D.R. Guyer Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 27 2004 2805 2816
35. M. Labetoulle, E. Frau, H. Offret, P. Nordmann, and T. Naas Non-preserved 1% lidocaine solution has less antibacterial properties than currently available anaesthetic eye-drops Curr Eye Res 25 2 2002 91 97
36. J. Tanner, S. Swarbrook, and J. Stuart Surgical hand antisepsis to reduce surgical site infection Cochrane Database Syst Rev 1 2008 CD004288
37. G. Ratnarajan, R. Nath, S. Appaswamy, and S.L. Watson Intravitreal injections using a novel conjunctival mould: a comparison with a conventional technique Br J Ophthalmol 97 4 2013 395 397
38. C. Chiquet, P.L. Cornut, and Y. Benito Eubacterial PCR for bacterial detection and identification in 100 acute postcataract surgery endophthalmitis Invest Ophthalmol Vis Sci 49 5 2008 1971 1978
39. M.P. Simunovic, R.B. Rush, A.P. Hunyor, and A.A. Chang Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes Br J Ophthalmol 96 6 2012 862 866
40. D. Mezad-Koursh, M. Goldstein, G. Heilwail, S. Zayit-Soudry, A. Loewenstein, and A. Barak Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor Retina 30 7 2010 1051 1057